Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery | MicrobiomeTrials← Back to trialsNCT03012971
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2017-01-06Est. Completion: 2026-12-11
Enrollment target: 1,500 participants Locations- Peking University First Hospital, Beijing, Beijing Municipality, China
- Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China
- Peking University International Hospital , , China, Contact:, Beijing, Beijing Municipality, China
- Chongqing University Fuling Hospital, Chongqing, Chongqing Municipality, China
- Guizhou Provincial People's Hospital , China, Contact:, Guiyang, Guizhou, China
- Affiliated Hospital of Hebei University, Baoding, Hebei, China
- The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
- The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China
- Qingdao Municipal Hospital , , China, Contact:, Qingdao, Shandong, China
- Shanxi Provincial Cancer Hospital , China, Contact:, Taiyuan, Shanxi, China
- Tianjin Hospital of ITCWM-Nankai Hospital, Tianjin, Tianjin Municipality, China
- The Third Central Hospital of Tianjin, Tianjin, Tianjin Municipality, China
Other microbiome trials you might be interested in
Nephropathic Cystinosis
An open-label, multi-center, phase I/II study to assess the safety, tolerability and efficacy of DFT383 in pediatric par…
San Diego, United StatesEst. completion May 28, 2031
PBC
Primary biliary cholangitis (PBC) is a chronic autoimmune intrahepatic cholestatic liver disease characterized by progre…
Beijing, ChinaEst. completion Jul 1, 2027
Genetic Predisposition to DiseaseHealthy VolunteerAPOE-4 Positive
Alzheimer's disease is a devastating neurodegenerative disease characterized by accumulation of clumps (also called plaq…
Columbia, United StatesEst. completion Dec 31, 2027